阅读说明：本技术 包含贝兰他单抗莫福汀和抗ox4抗体的癌症组合治疗及其用途和方法 (Combination cancer therapy comprising bevacizumab molefletin and anti-OX 4 antibody and uses and methods thereof ) 是由 S·比斯瓦斯 N·A·杰克逊 E·M·保罗 H·斯特朗姆珀 J·奥帕林斯卡 于 2020-01-31 设计创作，主要内容包括：本文公开了结合BCMA的抗原结合蛋白和结合免疫调节剂诸如PD-1或OX40的抗原结合蛋白的组合产品、其药物组合物、其用途和包括施用所述组合产品的治疗方法,包括在癌症中的用途。(Disclosed herein are combinations of antigen binding proteins that bind BCMA and antigen binding proteins that bind immunomodulators, such as PD-1 or OX40, pharmaceutical compositions thereof, uses thereof, and methods of treatment, including use in cancer, comprising administering the combinations.)